研發體系

長森藥業聚焦自身免疫疾病、腫瘤免疫治療、抗病毒等領域的創新藥研發與產業化，管線產品臨床評估指標均達到國際領先水平，有望成為相關領域的重大突破（FIC，first in class）。

長森藥業專注具有自主知識產權及國際領先水平的創新藥物的開發和醫學轉化，通過合作開發、Licensing Out等形式，積極參與國際競爭，解決尚未滿足的臨床需求。

了 解 更 多

R&D

Longwood Biopharma is focusing on the development and industrialization of innovative drugs in the fields of autoimmune diseases, tumor immunotherapy and anti-virus. With world-class performance in clinical evaluation, our pipelines are expected to become a major breakthrough in related fields (FIC, first in class).

Longwood Biopharma focuses on the development and medical translation of world-class innovative drugs with independent IPR, and actively participates in international competition through co-development and licensing-out to address unmet clinical needs.

Learn More